Tamir Biotechnology Inc - Company Review
Tamir Biotechnology Inc - Company ReviewSummary
Tamir Biotechnology Inc (Tamir Biotechnology), formerly Alfacell Corp is a clinical stage antiviral therapeutics company that discovers and develops prophylactic and therapeutic drugs for the treatment of viruses and other pathological conditions. The company’s targets include human papilloma virus and acute treatment of the Ebola virus. Its technology platform comprise ranpirnase, which is a ribonuclease that catalyzes the degradation of RNA, and mediates various biological activities. The company has documented considerable anti-viral activity for orthomyxoviruses, middle east respiratory syndrome, hepatitis c virus, rhabodviruses, and others. Tamir Biotechnology is headquartered in Short Hills, New Jersey, the US.
This comprehensive company report of Tamir Biotechnology Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.